Zhang Zhengrong, Deng Taomei, Wu Manli, Zhu Aisong, Zhu Guoqi
1Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Meishan Road 103, Hefei, 230038 China.
2School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230038 China.
Chin Med. 2019 Jul 15;14:24. doi: 10.1186/s13020-019-0246-9. eCollection 2019.
Depression is the most disastrous mood disorder affecting the health of individuals. Conventional treatments with chemical compounds for depression have limitations, while herbal medicine has unique therapeutic effects. This paper introduces the pharmacological basis and biological mechanisms underlying the botanical antidepressants over the past 5 years. Based upon the specific therapeutic targets or mechanisms, we analyzed the pathological roles of monoamine neurotransmitters, the hypothalamic-pituitary-adrenal axis, inflammation, oxidative stress, synaptic plasticity performed in antidepressant of the botanicals. In addition, gut flora and neurogenesis were also preferentially discussed as treatment approaches. Based on the complex pathogenesis of depression, we suggested that mixed use of botanicals, namely prescription would be more suitable for treatment of depression. In addition, neural circuit affected by botanicals or active components should also attract attention as the botanicals have potential to be developed into fast-acting antidepressants. Finally, gut flora might be a new systemic target for the treatment of depression by botanicals. This review would strength botanical medicine as the antidepressant and also provides an overview of the potential mechanisms involved.
抑郁症是影响个体健康的最具灾难性的情绪障碍。用化学化合物治疗抑郁症的传统方法存在局限性,而草药具有独特的治疗效果。本文介绍了过去5年中植物性抗抑郁药的药理学基础和生物学机制。基于特定的治疗靶点或机制,我们分析了单胺类神经递质、下丘脑-垂体-肾上腺轴、炎症、氧化应激、突触可塑性在植物性抗抑郁药中的病理作用。此外,肠道菌群和神经发生也作为治疗方法被优先讨论。基于抑郁症复杂的发病机制,我们认为混合使用植物药,即配方用药,将更适合治疗抑郁症。此外,由于植物药有潜力被开发成速效抗抑郁药,受植物药或其活性成分影响的神经回路也应引起关注。最后,肠道菌群可能是植物药治疗抑郁症的一个新的全身靶点。这篇综述将加强植物药作为抗抑郁药的作用,并概述其中涉及的潜在机制。